IBD clinical Roadmap 2023

MD Education are proud to introduce a new, virtual educational initiative for physicians and HCPs in IBD starting in January 2023 and running each month through to December 2023.

Each month, both chairs: Millie Long, MD and Raymond Cross, MD will meet with two leading IBD clinical experts to dive deep into the latest hot topics.

Each expert presentation will last around 20 minutes and will be accompanied by speaker slides that can be downloaded. Immediately following the presentations there will be a 15-20 minute Q&A session with the speakers and co-chairs.

Image hover effect image — Bio

Millie D. Long, MD

UNC School of Medicine

Image hover effect image — Bio

Raymond Cross, MD

University of Maryland

JANUARY

Management of Mental Health Disorders in Patients with IBD

Image hover effect image — Bio

Laurie Keefer

Icahn School Of Medicine, Mount Sinai, New York

Image hover effect image — Bio

Sara Horst

Vanderbilt IBD Clinic

Video & Information

FEBRUARY

Updates in Management of Perianal Crohn’s Disease

Image hover effect image — Bio

David Schwartz

Vanderbilt IBD Clinic

Image hover effect image — Bio

Amy Lightner

Cleveland Clinic

Video & Information

MARCH

Classification and Management of Pouch Disorders

Image hover effect image — Bio

Ed Barnes

UNC School of Medicine

Image hover effect image — Bio

Jami Kinnucan

Mayo Clinic, Florida

Video & Information

APRIL

Women’s Health in IBD: Preconception to Menopause

Image hover effect image — Bio

Uma Mahadevan

UCSF Colitis and Crohn’s Disease Center

Image hover effect image — Bio

Sonia Friedman

BWH Crohn’s & Colitis Center

Video & Information

WORLD IBD DAY | 19 May 2023

MAY

Health Maintenance in IBD

Image hover effect image — Bio

Frank Farraye

Mayo Clinic, Florida

Image hover effect image — Bio

Freddy Caldera

University of Wisconsin School of Medicine and Public Health

Medical & Surgical Approaches in Patients with Acute Severe Colitis

Image hover effect image — Bio

Neil Hyman

University of Chicago

Image hover effect image — Bio

Parambir Dulai

Northwestern Medicine

WORLD IBD DAY | 19 May 2023

MAY

Health Maintenance in IBD

Medical & Surgical Approaches in Patients with Acute Severe Colitis

Image hover effect image — Bio

Frank Farraye

Mayo Clinic, Florida

Image hover effect image — Bio

Freddy Caldera

University of Wisconsin School of Medicine and Public Health

Image hover effect image — Bio

Neil Hyman

University of Chicago

Image hover effect image — Bio

Parambir Dulai

University of Chicago

Video & Information

Video & Information

JUNE

Dysplasia Surveillance in Chronic Colitis: Who, when, how, and how often?

Image hover effect image — Bio

Samir Shah

Brown University

Image hover effect image — Bio

Kofi Clarke

Penn State College of Medicine

Video & Information

JULY

Post Operative Crohn’s Disease

Image hover effect image — Bio

Miguel Regueiro

Cleveland Clinic

Image hover effect image — Bio

Oriana Damas

University of Miami Health System

Video & Information

AUGUST

Positioning Highly Effective Therapy in CD

Image hover effect image — Bio

Alan C. Moss

Boston Medical Centre, Massachusetts

Image hover effect image — Bio

Meena Bewtra

Penn Medicine

Video & Information

SEPTEMBER

Positioning Highly Effective Therapy in UC

Image hover effect image — Bio

Gary Lichtenstein

Penn Medicine

Image hover effect image — Bio

Lisa Malter

NYU Grossman School of Medicine

Video & Information

OCTOBER

Classification and Management of Extraintestinal Manifestations

Image hover effect image — Bio

Florian Rieder

Cleveland Clinic

Image hover effect image — Bio

Kara De Felice

University of Cincinnati

Video & Information

NOVEMBER

Treat to Target and Therapeutic Monitoring in IBD

Image hover effect image — Bio

Steve Hanauer

Northwestern University

Image hover effect image — Bio

Marla Dubinsky

Icahn School Of Medicine, Mount Sinai, New York

Video & Information

CROHN’S & COLITIS AWARENESS WEEK | 1-7 December 2023

DECEMBER

Management of Refractory and Complicated Crohn’s Disease

Managing IBD from Pediatrics to the Elderly

Image hover effect image — Bio

Corey Siegel

The Dartmouth Institute for Health

Image hover effect image — Bio

Kim Isaacs

UNC School of Medicine

Image hover effect image — Bio

Mike Rosen

Stanford University

Image hover effect image — Bio

Bharati Kochar

Massachusetts General Hospital

Video & Information

Video & Information

End of Year

End of year Discussion

Image hover effect image — Bio

Corey Siegel

The Dartmouth Institute for Health

Image hover effect image — Bio

Meena Bewtra

Penn Medicine

Image hover effect image — Bio

Sara Horst

Vanderbilt IBD Clinic

Image hover effect image — Bio

Steve Hanauer

Northwestern University

Video & Information

CROHN’S & COLITIS AWARENESS WEEK | 1-7 December 2023

DECEMBER

Management of Refractory and Complicated Crohn’s Disease

Image hover effect image — Bio

Corey Siegel

The Dartmouth Institute for Health

Image hover effect image — Bio

Kim Isaacs

UNC School of Medicine

Managing IBD from Pediatrics to the Elderly

Image hover effect image — Bio

Mike Rosen

Stanford University

Image hover effect image — Bio

Bharati Kochar

Massachusetts General Hospital

FACULTY REVIEW

FACULTY GROUP REVIEW AT THE END OF THE 12 MONTHS TO REFLECT ON KEY DEVELOPMENTS

If you would like additional information or have any questions, please email:

office@md-education.com

ORGANISED BY:

Privacy Policy | Cookie Policy

Developed by Unet

Dr. Uma Mahadevan is a gastroenterologist and clinical scientist specializing in inflammatory bowel disease (IBD), particularly pregnancy and drug safety. She completed a medical degree at the State University of New York in Brooklyn, residency in internal medicine at Mount Sinai Medical Center in New York, and a fellowship in gastroenterology at the University of California, San Francisco (UCSF). She did an advanced fellowship in IBD at the Mayo Clinic, Rochester, Minnesota. Dr. Mahadevan currently serves as Professor of Medicine at UCSF, Director of the UCSF Colitis and Crohn’s Disease Center and Director of the Advanced IBD Fellowship. For her exceptional work in pregnancy and drug safety and her mentoring of GI fellows and junior faculty she received the AGA 2022 Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award and the 2022 Sherman Prize.

Certified by the American Board of Internal Medicine as a Diplomate in internal medicine and gastroenterology, Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she was Chair for the IMIBD Section, Chair of the AGA National IBD Parenthood initiative and Director (2023) and co-Director (2022, 2017) of the AGA Postgraduate Course. She is a Fellow of the American College of Gastroenterology and served on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee. She was Chair of the Crohns Colitis Foundation Clinical Research Grants committee, a member of the National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress (2020).

Dr. Mahadevan has served on many prestigious journals, including special section editor for Gastroenterology. Dr. Mahadevan has published over 100 original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, Gut, Nature Reviews, American Journal of Gastroenterology, Inflammatory Bowel Diseases, and Lancet Gastroenterology Hepatology as well as several book chapters. She authored the joint AGA, Society of Maternal Fetal Medicine Clinical Care Pathway on the Management of IBD in Pregnancy.

Dr. Mahadevan specializes in the treatment of complex ulcerative colitis and Crohn’s disease. She is a global expert on the management of pregnancy and drug safety in the patient with IBD. She is also interested in the role of diet and IBD and has an ongoing original study in this area. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO), clinical trials in biologic therapy for IBD, and the impact of nutritional interventions in the management of IBD (SEAMUS). She has an interest in digital health and lead the transition of the GI Division to telemedicine at the start of the pandemic in March 2020 and has developed an IBD Chatbot with the Center for Digital Health and Innovation at UCSF. This IBD Chat can remotely monitor thousands of patients with IBD and integrate with the existing electronic health record. Additionally, in collaboration with data scientists at UCSF, she is studying ways to answer important questions in IBD using the UCSF electronic health record.

Dr. Mahadevan is proud to have mentored several Advanced IBD Fellows who know hold key roles in IBD Centers around the United States.

Alan C Moss MD, FACG, FEBG, AGAF, FRCPI

Current Academic / Administrative Roles
Director, Crohn’s & Colitis Program, Boston Medical Center
Professor of Medicine, Boston University School of Medicine
Interim Chief, Gastroenterology Section, Boston Medical Center

Education

Medical School – Royal College of Surgeons in Ireland 1997
Medical Doctorate (by research) – University College Dublin, 2002-2004

Prior Academic / Administrative Roles

Associate Professor of Medicine, Harvard Medical School
Gastroenterologist, Beth Israel Deaconess Medical Center (BIDMC)
Director of Translational Research, IBD Center, BIDMC
Director of IBD Fellowship, BIDMC

Key Honors & Awards

Fellow of the American College of Gastroenterology, American Gastroenterology Association,
European Board of Gastroenterology, and Royal College of Physicians
Goldwitz-Allen Memorial Lectureship, State University of New York
Keynote Speaker, Translational Microbiome Research Summit, Microbiome Center at MIT
Visiting Professor; University College Dublin, University of Barcelona, Trinity College School of
Medicine
Humanitarian of the Year, Crohn’s & Colitis Foundation, New England Chapter

Key National / International Committees

National Immunology & Inflammatory Bowel Diseases Section, AGA Institute Council (2012-2014)
Pilot Study Steering Committee, CCFA Clinical Research Alliance
National Professional Education Committee, Crohn’s & Colitis Foundation
Planning Committee, AGA Freston Conference on Microbiome Therapy (2016)
Advisory Committee, NIH Common Fund Extracellular RNA Communication Program (2017)
National Scientific Advisory Committee, Crohn’s & Colitis Foundation

Key International Editorial Roles

Deputy Editor; Crohn’s & Colitis 360 (Crohn’s & Colitis Foundation)
Associate Editor; Journal of Crohn’s & Colitis (ECCO), Frontline Gastroenterology (BMJ), World
Journal of Gastroenterology
Peer Reviewer; NEJM, JAMA, Gastroenterology, BMJ, Gastroenterology, Gut, Am J Gastroenterology
Grant Reviewer; NIH, Broad Medical Research Foundation, Netherlands Organization for Research,
Israel Science Foundation, European Research Council
Section Head (GI disease); New England Journal of Medicine Knowledge Plus

Academic Publications Summary

Over 200 peer-reviewed papers, cited by over 2000 independent papers (h-index : 28)
Published research in; Gut, Clinical Gastroenterology & Hepatology, American Journal of
Gastroenterology, Inflammatory Bowel Diseases, European Journal of Immunology, J Crohn’s & Colitis

Grant Funding History

Federal – NIDDK
Foundations – Helmsley Charitable Trust, AGA Foundation, Crohn’s & Colitis Foundation
Industry – Pfizer, Takeda

Marla C. Dubinsky, MD, is a Professor of Pediatrics and Medicine at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dubinsky received her medical degree from Queen’s University, Canada. She completed her pediatric residency at Alberta Children’s Hospital, Calgary, Canada, and her clinical fellowship in gastroenterology and nutrition at Sainte-Justine Hospital at the University of Montreal, Canada. She completed her research fellowship in IBD at Cedars-Sinai Medical Center in Los Angeles, CA, where she served as the Director of the Pediatric IBD Center before going to Mount Sinai as the Chief of Pediatric Gastroenterology and Nutrition at the Mount Sinai Kravis Children’s Hospital and Co-Director of the Susan and Leonard Feinstein IBD Clinical Center. Dr. Dubinsky is also the Co-Director of the IBD Preconception and Pregnancy Planning Clinic at Mount Sinai. She is the Co-Founder of Mi-Test Health, and Cornerstones Health which is a non-profit organization dedicated to enhancing and transforming communication between health care providers, patients, and industry partners through creative, comprehensive, and expert-based educational program. She is also the Co-Founder of Trellus Health, a resilience driven connected health solution for chronic conditions.

Dr. Dubinsky has been engaged in inflammatory bowel disease (IBD) clinical and translational research for over two decades. Dr. Dubinsky’s primary research focuses on developing predictive models and web-based decision support tools that integrate clinical and biomarkers to predict the natural history of IBD and response to therapy. She has a keen interest in personalized medicine in IBD and her research uncovers predictors of rapid disease progression with the goal of preventing complications by altering treatment plans. Dr. Dubinsky is the principal investigator of multiple large longitudinal cohorts including the Road to Prevention Multiplex Family Program at Mount Sinai with over 700 enrolled participants with a goal of using multi-omic data to predict the development of IBD in unaffected family members and co-investigator of the Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn’s Disease (RISK) study and senior author on the manuscript presenting a model to predict the natural history of pediatric Crohn’s disease. Dr. Dubinsky is very committed to women’s reproductive health in IBD and in addition to her research in this field she is the Co-founder of WECARE in IBD, an organization dedicated to the health of women with IBD. She has lectured widely, both nationally and internationally, and has published in more than 260 peer-reviewed journals, including Gastroenterology, Lancet, JAMA, The Journal of Pediatric Gastroenterology and Nutrition, The journal of Crohn’s and Colitis, Inflammatory Bowel Diseases, and the American Journal of Gastroenterology.